Avanos Medical, Inc.
AVNS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$392,100 | -$61,800 | $50,500 | $5,200 |
| Dep. & Amort. | $45,500 | $46,100 | $47,700 | $38,300 |
| Deferred Tax | $0 | $0 | $0 | -$3,400 |
| Stock-Based Comp. | $13,800 | $15,800 | $15,900 | $13,200 |
| Change in WC | $35,000 | -$18,000 | -$24,300 | $26,000 |
| Other Non-Cash | $398,500 | $50,300 | $1,100 | $8,000 |
| Operating Cash Flow | $100,700 | $32,400 | $90,900 | $87,300 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$17,800 | -$17,800 | -$19,300 | -$21,000 |
| Net Acquisitions | -$9,700 | $39,400 | -$116,100 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$27,500 | $21,600 | -$135,400 | -$21,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$33,600 | -$64,700 | $103,400 | -$50,000 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$12,800 | -$19,100 | -$45,500 | -$11,500 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,700 | -$10,400 | -$1,200 | $6,200 |
| Financing Cash Flow | -$49,100 | -$94,200 | $56,700 | -$55,300 |
| Forex Effect | -$4,100 | $200 | -$3,000 | -$4,000 |
| Net Chg. in Cash | $20,000 | -$40,000 | $9,200 | $7,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $87,700 | $127,700 | $118,500 | $111,500 |
| End Cash | $107,700 | $87,700 | $127,700 | $118,500 |
| Free Cash Flow | $82,900 | $14,600 | $71,600 | $66,300 |